Quickly analyze and visualize real-world patient data sets to instantly obtain answers to access barriers and prescribing patterns. Patient Access Analytics—from MMIT and Panalgo, both Norstella companies—combines coverage data and claims data to provide commercial pharma teams with a unique view of payer and prescriber behavior.
The Strategic Launch Report—from MMIT, a Norstella company—provides drug manufacturers with a realistic view of payers’ coverage adoption rates and utilization management within the first year post-launch. The report is paired with consensus forecast data from Evaluate, a Norstella company, for currently approved and pipeline agents within the target indication, to help you identify competitors and challenges and proactively plan your near- and long-term strategies.
Engaging stakeholders at oncology accounts is becoming increasingly more complex as the market continues to evolve and grow. PULSE Analytics, from The Dedham Group, has the data you need to pave the way to market access success.
With PULSE Analytics, you can:
We’re looking for agile, growth-oriented team players who are passionate about client success and helping clients bring life-saving therapies to market quicker—and help patients in need.
Work with usHave questions about Norstella or its brands? Or do you want to know more about how to solve your challenges at each stage of the drug life cycle?
We want to hear from you